SCLX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.65%

Insider Buying (Last 12 Months): $230,445.95

Insider Selling (Last 12 Months): $0.00

Scilex Insider Trading History Chart

Scilex Share Price & Price History

^$4.86

▼ -0.095 (-1.92%)

As of 04/29/2025 03:23 PM ET

Days: 30 | 90 | 365

Scilex Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/18/2024	Jaisim Shah	Insider	Buy	857	$16.10	$13,797.70	3,980
10/31/2024	Henry Ji	Insider	Buy	253	$32.90	$8,323.70	9,147
10/29/2024	Jaisim Shah	Insider	Buy	914	$34.65	$31,670.10	3,123
10/17/2024	Yue Alexander Wu	Director	Buy	571	$33.25	$18,985.75	714
10/16/2024	Jaisim Shah	Insider	Buy	857	$34.65	$29,695.05	2,209
10/16/2024	Stephen Hoi Ma	CFO	Buy	191	$33.95	$6,484.45	652
5/17/2024	Jay Chun	Director	Buy	1,642	$31.50	$51,723.00	2,928
5/16/2024	Jaisim Shah	Insider	Buy	2,373	$29.40	$69,766.20	2,826

SEC Filings (Institutional Ownership Changes) for Scilex (NASDAQ:SCLX)

69.67% of Scilex stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Scilex Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Janus Henderson Group PLC	687,547	$0.29M	0.0%	+28.7%	0.283%
2/14/2025	RA Capital Management L.P.	1,036,218	$0.44M	0.0%	+296.7%	0.426%
2/14/2025	Jane Street Group LLC	321,480	$0.14M	0.0%	+965.8%	0.132%
2/14/2025	Northern Trust Corp	1,273,968	$0.54M	0.0%	+64.0%	0.524%
2/12/2025	Geode Capital Management LLC	1,248,689	$0.53M	0.0%	-3.6%	0.513%
2/12/2025	Norges Bank	477,619	$0.20M	0.0%	N/A	0.196%
1/23/2025	Donald L. Hagan LLC	173,292	$74K	0.0%	+32.5%	0.090%
11/15/2024	XTX Topco Ltd	86,335	$80K	0.0%	-18.1%	0.045%
11/15/2024	Jane Street Group LLC	30,164	$28K	0.0%	-89.1%	0.016%
11/15/2024	State Street Corp	7,484,310	$6.92M	0.0%	+0.7%	3.902%
11/15/2024	Janus Henderson Group PLC	534,302	$0.49M	0.0%	+3.5%	0.279%
10/31/2024	Donald L. Hagan LLC	130,792	$0.12M	0.1%	+15.4%	0.068%
8/15/2024	The Manufacturers Life Insurance Company	12,935	$25K	0.0%	N/A	0.007%
8/15/2024	Armistice Capital LLC	11,950,000	$23.06M	0.3%	N/A	6.595%
8/12/2024	XTX Topco Ltd	105,431	$0.20M	0.0%	+321.4%	0.058%
7/26/2024	Bank of New York Mellon Corp	15,815	$31K	0.0%	N/A	0.009%
7/19/2024	Donald L. Hagan LLC	113,292	$0.22M	0.1%	+59.5%	0.063%
5/10/2024	Vanguard Group Inc.	3,988,265	$6.34M	0.0%	+1.4%	2.400%
4/17/2024	Cannon Global Investment Management LLC	25,000	$40K	0.1%	N/A	0.015%
4/9/2024	Collective Family Office LLC	21,950	$35K	0.0%	+68.4%	0.013%
2/13/2024	Tower Research Capital LLC TRC	20,595	$42K	0.0%	-82.7%	0.013%
2/12/2024	Focus Financial Network Inc. ADV	28,257	$58K	0.0%	N/A	0.018%
2/6/2024	Apollon Wealth Management LLC	36,100	$74K	0.0%	-27.8%	0.023%
1/19/2024	Donald L. Hagan LLC	52,343	$0.11M	0.1%	+49.1%	0.033%
12/7/2023	Hudson Bay Capital Management LP	474,683	$0.67M	0.0%	N/A	0.301%
10/24/2023	Bank of New York Mellon Corp	48,459	$68K	0.0%	N/A	0.032%
10/11/2023	Donald L. Hagan LLC	35,098	$49K	0.0%	+39.8%	0.023%
8/14/2023	Casdin Capital LLC	23,512	$0.13M	0.0%	N/A	0.016%
8/11/2023	Deuterium Capital Management LLC	23,994	$96K	0.1%	+25.8%	0.016%
8/10/2023	Ground Swell Capital LLC	12,085	$67K	0.2%	N/A	0.008%
8/7/2023	Wolverine Asset Management LLC	8,224	$46K	0.0%	N/A	0.006%
7/17/2023	Donald L. Hagan LLC	25,098	$0.14M	0.1%	+66.2%	0.017%
7/17/2023	GoalVest Advisory LLC	7,279	$41K	0.0%	N/A	0.005%
6/14/2023	State Board of Administration of Florida Retirement System	14,219	$0.12M	0.0%	N/A	0.010%
5/11/2023	Citigroup Inc.	239,130	$1.96M	0.0%	N/A	0.164%
5/11/2023	E Fund Management Co. Ltd.	31,431	$0.26M	0.0%	N/A	0.022%
5/9/2023	Tower Research Capital LLC TRC	10,538	$86K	0.0%	+1,159.0%	0.007%
5/9/2023	California State Teachers Retirement System	81,066	$0.67M	0.0%	N/A	0.056%
5/9/2023	US Bancorp DE	4,512	$37K	0.0%	N/A	0.003%
5/8/2023	New York Life Investment Management LLC	34,109	$0.28M	0.0%	N/A	0.023%
5/8/2023	Public Employees Retirement Association of Colorado	4,709	$39K	0.0%	N/A	0.003%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	8,554	$70K	0.0%	N/A	0.006%
5/5/2023	Mayo Clinic	42,303	$0.35M	0.3%	N/A	0.029%
5/2/2023	Amalgamated Bank	8,654	$71K	0.0%	N/A	0.006%
4/28/2023	Handelsbanken Fonder AB	11,168	$92K	0.0%	N/A	0.008%
4/27/2023	Arizona State Retirement System	17,904	$0.15M	0.0%	N/A	0.012%
4/18/2023	Donald L. Hagan LLC	15,098	$0.12M	0.1%	N/A	0.010%
4/18/2023	ETF Managers Group LLC	16,589	$0.14M	0.0%	N/A	0.011%
4/14/2023	Raymond James Financial Services Advisors Inc.	18,409	$0.15M	0.0%	N/A	0.013%
4/14/2023	Raymond James & Associates	31,303	$0.26M	0.0%	N/A	0.021%
4/11/2023	Asset Management Resources LLC	19,459	$0.16M	0.1%	N/A	0.013%

Data available starting January 2016

See Full Table

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company is also developing three product candidates, including SP-102 (10 mg dexamethasone sodium phosphate viscous gel) (SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a Phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4% (SP-103), a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a Phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules) (SP-104), a novel low-dose delayed-release naltrexone hydrochloride, which has completed Phase 1 trials for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California.

Today's Range

Now: $4.86

$4.72

$5.74

50 Day Range

MA: $8.77

$3.99

$12.25

52 Week Range

Now: $4.86

$3.60

$80.50

Volume

223,965 shs

Average Volume

48,724 shs

Market Capitalization

$33.79 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of Scilex?: Scilex's top insider investors include:
Henry Ji (Insider)
Jaisim Shah (Insider)
Jay Chun (Director)
Yue Alexander Wu (Director)
Stephen Hoi Ma (CFO)
Learn More about top insider investors at Scilex.